One study showed that the mesenteric vessel walls in patients with IBD had increased levels of plasminogen activator inhibitor of type 1 (PAI-1) and decreased levels of tissue-type plasminogen activator (t-PA) and urokinase-type plasminogen activator (u-PA) [93]. This evidence concerns the gene PLAU and inflammatory bowel disease.